Article
Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association - 1 Sept 2021
Steeghs Elisabeth M P, Gelderblom Hans, Ho Vincent K Y, Voorham Quirinus J M, Willems Stefan M, Grünberg Katrien, Ligtenberg Marjolijn J L
Abstract excerpt
BACKGROUND: Molecular analysis of KIT and PDGFRA is critical for tyrosine kinase inhibitor treatment selection of gastrointestinal stromal tumors (GISTs) and hence recommended by international guidelines. We performed a nationwide study into the application of predictive mutation testing in GIST patients and its impact on targeted treatment decisions in clinical practice. METHODS: Real-world clinical and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
